T2 Biosystems to Participate in the Canaccord Genuity Annual Growth Conference

LEXINGTON, Mass., July 30, 2020 (GLOBE NEWSWIRE) — T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, today announced that the Company plans to participate in the upcoming virtual Canaccord Genuity Annual Growth Conference.
Management is scheduled to present Thursday, August 13, 2020 at 9:30am ET. Interested parties may access a live and recorded webcast of the presentation on the “Investors” section of the Company’s website at www.t2biosystems.comMedia Contact:
Gina Kent, Vault Communications
[email protected]  
610-455-2763
Investor Contact:
Philip Trip Taylor, Gilmartin Group
[email protected]
415-937-5406


Bay Street News

Contact Us

We're not around right now. But you can send us an email and we'll get back to you, asap.

Not readable? Change text. captcha txt

Start typing and press Enter to search